News Focus
News Focus
Followers 5
Posts 509
Boards Moderated 0
Alias Born 06/11/2024

Re: JRoon71 post# 441115

Friday, 11/14/2025 12:46:39 PM

Friday, November 14, 2025 12:46:39 PM

Post# of 446772
That fear might be valid but why would Edding partner and pay $20m? Given the high approval hit rate I would anticipate approval with the price being the key aspect. As long as China negotiates a sufficiently cheap deal, why not take the proven branded option? We passed Chinese regulatory approval in 2024... did the generics in question also attain approval? Didn't the approval come with some exclusivity?
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News